Lipid droplets in cancer: A review of their implications for tumor biology and treatment

Kelly Osayi Otakhor, Elizabeth O. Soladoye
{"title":"Lipid droplets in cancer: A review of their implications for tumor biology and treatment","authors":"Kelly Osayi Otakhor, Elizabeth O. Soladoye","doi":"10.30574/wjarr.2024.23.1.2037","DOIUrl":null,"url":null,"abstract":"Lipid droplets (LDs) are intracellular organelles traditionally known for their role in lipid storage and energy homeostasis. Recent research has unveiled their significant involvement in cancer biology, revealing them as dynamic structures that contribute to various aspects of tumor development and progression. This review delves into the multifaceted roles of LDs in cancer, highlighting their implications for tumor biology and potential therapeutic strategies. LDs are increasingly recognised for their ability to modulate cellular metabolism, signaling pathways, and stress responses in cancer cells. Their accumulation is often observed in various tumor types, correlating with aggressive phenotypes and poor prognosis. LDs support rapid cell proliferation by providing essential lipids for membrane synthesis and energy production, enabling cancer cells to thrive under metabolic stress. Furthermore, LDs serve as hubs for lipid signaling molecules, influencing key oncogenic pathways such as the PI3K/Akt/mTOR and Wnt/β-catenin pathways, thereby promoting tumorigenesis and metastasis. Beyond their metabolic functions, LDs contribute to the oxidative stress response and lipid peroxidation, mechanisms that can either facilitate cancer cell survival or lead to cell death, depending on the context. The dual role of LDs in regulating reactive oxygen species (ROS) levels underscores their complexity in cancer biology. Importantly, LDs have emerged as potential targets for cancer therapy. Strategies to disrupt LD formation, enhance lipid catabolism, or modulate lipid signaling are being explored to impair tumor growth and sensitize cancer cells to treatment. Pharmacological agents targeting LD-associated proteins, such as perilipins and diacylglycerol acyltransferase (DGAT) inhibitors, are showing promise in preclinical models. LDs play a critical and versatile role in cancer biology, influencing tumor metabolism, signaling, and stress responses. Understanding the intricate functions of LDs in cancer can pave the way for novel therapeutic approaches, offering hope for more effective treatments in oncology. This review underscores the need for further research to fully elucidate the therapeutic potential of targeting LDs in cancer.","PeriodicalId":23739,"journal":{"name":"World Journal of Advanced Research and Reviews","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Advanced Research and Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30574/wjarr.2024.23.1.2037","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Lipid droplets (LDs) are intracellular organelles traditionally known for their role in lipid storage and energy homeostasis. Recent research has unveiled their significant involvement in cancer biology, revealing them as dynamic structures that contribute to various aspects of tumor development and progression. This review delves into the multifaceted roles of LDs in cancer, highlighting their implications for tumor biology and potential therapeutic strategies. LDs are increasingly recognised for their ability to modulate cellular metabolism, signaling pathways, and stress responses in cancer cells. Their accumulation is often observed in various tumor types, correlating with aggressive phenotypes and poor prognosis. LDs support rapid cell proliferation by providing essential lipids for membrane synthesis and energy production, enabling cancer cells to thrive under metabolic stress. Furthermore, LDs serve as hubs for lipid signaling molecules, influencing key oncogenic pathways such as the PI3K/Akt/mTOR and Wnt/β-catenin pathways, thereby promoting tumorigenesis and metastasis. Beyond their metabolic functions, LDs contribute to the oxidative stress response and lipid peroxidation, mechanisms that can either facilitate cancer cell survival or lead to cell death, depending on the context. The dual role of LDs in regulating reactive oxygen species (ROS) levels underscores their complexity in cancer biology. Importantly, LDs have emerged as potential targets for cancer therapy. Strategies to disrupt LD formation, enhance lipid catabolism, or modulate lipid signaling are being explored to impair tumor growth and sensitize cancer cells to treatment. Pharmacological agents targeting LD-associated proteins, such as perilipins and diacylglycerol acyltransferase (DGAT) inhibitors, are showing promise in preclinical models. LDs play a critical and versatile role in cancer biology, influencing tumor metabolism, signaling, and stress responses. Understanding the intricate functions of LDs in cancer can pave the way for novel therapeutic approaches, offering hope for more effective treatments in oncology. This review underscores the need for further research to fully elucidate the therapeutic potential of targeting LDs in cancer.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
癌症中的脂滴:综述脂滴对肿瘤生物学和治疗的影响
脂滴(LDs)是一种细胞内细胞器,传统上因其在脂质储存和能量平衡中的作用而闻名。最近的研究揭示了它们在癌症生物学中的重要作用,揭示了它们作为动态结构对肿瘤发生和发展的各个方面所起的作用。这篇综述深入探讨了 LDs 在癌症中的多方面作用,强调了它们对肿瘤生物学和潜在治疗策略的影响。LDs 能够调节癌细胞的细胞代谢、信号通路和应激反应,因此越来越受到人们的重视。在各种肿瘤类型中经常可以观察到它们的积累,这与侵袭性表型和不良预后有关。低密度脂蛋白为细胞膜的合成和能量的产生提供必需的脂质,从而支持细胞的快速增殖,使癌细胞能够在代谢压力下茁壮成长。此外,LDs 还是脂质信号分子的枢纽,影响着关键的致癌通路,如 PI3K/Akt/mTOR 和 Wnt/β-catenin 通路,从而促进肿瘤发生和转移。除了代谢功能外,低密度脂蛋白还有助于氧化应激反应和脂质过氧化反应,根据具体情况,这些机制既可促进癌细胞存活,也可导致细胞死亡。低密度脂蛋白在调节活性氧(ROS)水平方面的双重作用凸显了其在癌症生物学中的复杂性。重要的是,LDs 已成为癌症治疗的潜在靶点。目前正在探索破坏 LD 形成、促进脂质分解或调节脂质信号转导的策略,以损害肿瘤生长并使癌细胞对治疗敏感。针对 LD 相关蛋白的药剂,如周脂素和二酰基甘油酰基转移酶(DGAT)抑制剂,正在临床前模型中显示出良好的前景。低密度脂蛋白在癌症生物学中发挥着重要而多变的作用,影响着肿瘤的新陈代谢、信号传导和应激反应。了解 LDs 在癌症中错综复杂的功能可以为新型治疗方法铺平道路,为更有效的肿瘤治疗带来希望。这篇综述强调了进一步研究的必要性,以充分阐明靶向 LDs 在癌症中的治疗潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The relationship between income from fish farming and pupil’s retention in primary schools in Amolator district, Uganda A GIS-based land suitability assessment of wheat production in Kano using selected physical parameters Nanotechnology applications in breast implant manufacturing for improved durability and functionality Challenges and perspectives of total hip arthroplasty in young adults: A study of 74 patients The influence of the workplace environment on the behavior of health workers who breastfeed in Kupang Regency
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1